Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | DGKA | P23743 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16744077 | 0.92 | THRB (0.61) | THRBTSHRMAPTBLMADRA2A | |
| SCHEMBL124287 | 0.92 | THRB (0.61) | THRBTSHRMAPTBLMADRA2A | |
| SCHEMBL20691517 | 0.89 | THRB (0.44) | THRBTSHRMAPTBLMADRA2A | |
| SCHEMBL1478120 | 0.86 | THRB (0.55) | THRBTSHRMAPTBLMADRA2A | |
| SCHEMBL28959481 | 0.86 | THRB (0.66) | THRBTSHRMAPTBLMADRA2A | |
| SCHEMBL2466488 | 0.86 | THRB (0.59) | THRBTSHRMAPTBLMADRA2A | |
| SCHEMBL31091784 | 0.85 | THRB (0.50) | THRBTSHRMAPTBLMADRA2A | |
| Zinc Ion SCHEMBL31091778 | 0.85 | THRB (0.50) | THRBTSHRMAPTBLMADRA2A | |
| SCHEMBL10708376 | 0.85 | THRB (0.50) | THRBTSHRMAPTBLMADRA2A | |
| SCHEMBL31091783 | 0.85 | THRB (0.50) | THRBTSHRMAPTBLMADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11655314-B2 | Photoinitiators for light-curable compositions | TECHNISCHE UNIVERSITAET WIEN (AT) | 2023-05-23 | — | — | US | disclosed |
| US-11655314-B2 | Photoinitiators for light-curable compositions | TECHNISCHE UNIVERSITAET WIEN (AT) | 2023-05-23 | — | — | US | disclosed |
| US-11518823-B2 | Photoinitiators for light-curable compositions | TECHNISCHE UNIVERSITAET WIEN (AT) | 2022-12-06 | — | — | US | disclosed |
| US-20220235153-A1 | PHOTOINITIATORS FOR LIGHT-CURABLE COMPOSITIONS | TECHNISCHE UNIVERSITAET WIEN (AT) | 2022-07-28 | — | — | US | disclosed |
| US-20200231531-A1 | PHOTOINITIATORS FOR LIGHT-CURABLE COMPOSITIONS | TECHNISCHE UNIVERSITAET WIEN (AT) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11655314-B2 | Photoinitiators for light-curable compositions | OXER1, PPOX, ORC3 | THRB 1740/4885TSHR 2459/4885MAPT 2721/4885 |
| US-11518823-B2 | Photoinitiators for light-curable compositions | OXER1, ORC3, PPOX | THRB 1117/4885TSHR 1831/4885MAPT 2699/4885 |
| US-20220235153-A1 | PHOTOINITIATORS FOR LIGHT-CURABLE COMPOSITIONS | OXER1, PPOX, ORC3 | THRB 1740/4885TSHR 2459/4885MAPT 2721/4885 |
| US-20200231531-A1 | PHOTOINITIATORS FOR LIGHT-CURABLE COMPOSITIONS | OXER1, ORC3, PPOX | THRB 1117/4885TSHR 1831/4885MAPT 2699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.